- NEWS RELEASE -
Koning Breast CT Introduced at RSNA
West Henrietta, New York… Koning Corporation today announced the introduction
of its Cone Beam CT system, Koning Breast CT (KBCT) at the 98th annual Radiological
Society of North America Meeting (RSNA) in Chicago.
KBCT is the first commercially available, fully-integrated, low dose dedicated breast
CT scanner designed specifically to image the entire breast with high spatial and
contrast resolution. KBCT consists of a cushioned exam table with a cutout in the
center combined with a horizontal X-ray assembly. The patient lies face down with
the breast suspended through the opening. Hundreds of images of the entire breast
are taken in a 360 degree circle in less than 10 seconds without compression of
the breast tissue. Volumetric images are then presented on a high resolution display
in ultra-thin multi-slice/ multiplaner format as well as full 3D isotropic resolution..
Unlike current 2D diagnostic mammography, which has well recognized limitations,
KBCT virtually eliminates tissue overlap and superimposition of structures. It is
the tissue overlap and superimposition of structure which is often responsible for
the failure to diagnose breast cancer early when it is most treatable. Thus, the
new KBCT technology has the potential to detect breast cancer earlier, saving lives
and reducing ever growing health care costs.
Clinical studies indicate that KBCT has the potential to supplement and/or replace
other breast imaging modalities as well, to include Breast MRI, Ultrasound and Stereotactic
KBCT Has received the CE Mark and is approved for sale in the European Union. Approval
in the USA and China is expected as early as next year.
Koning Corporation, founded in 2002, is an International Medical Imaging Company
with offices in West Henrietta, New York and Tianjin, China (Koning Tianjin Medical
Equipment Co. LTD), developing and marketing “state of the art” Cone Beam CT Scanners
for the detection, diagnosis and treatment of diseases and other medical applications.
Development of the KBCT technology and system has been Supported in part by NIH/NCI
SBIR grant (1R44 CA103236 ) and SBIR Bridge Grant (2R44 CA 103236-05 ).
Senior VP Sales and Marketing
Ruola Ning PhD
President, Founder and CTO